[Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].
Sekikawa
Takashi
T
Department of Gastroenterology, Showa University, Toyosu Hospital.
Akaike
Akiko
A
Ushio
Jun
J
Sato
Atsushi
A
Matsukawa
Masaaki
M
D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D000077146:Irinotecan; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin